BR9803968A - Bifenilsulfonilcianamidas, processo para sua preparação e seu uso como medicamento. - Google Patents

Bifenilsulfonilcianamidas, processo para sua preparação e seu uso como medicamento.

Info

Publication number
BR9803968A
BR9803968A BR9803968-7A BR9803968A BR9803968A BR 9803968 A BR9803968 A BR 9803968A BR 9803968 A BR9803968 A BR 9803968A BR 9803968 A BR9803968 A BR 9803968A
Authority
BR
Brazil
Prior art keywords
medicine
preparation
ischemic
biphenylsulfonylcyanamides
induced
Prior art date
Application number
BR9803968-7A
Other languages
English (en)
Inventor
Heinz-Werner Dr Kleemann
Jan-Robert Dr Schwark
Sabine Dr Faber
Hans Jochen Dr Lang
Andreas Dr Weichert
Hans-Willi Dr Jansen
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of BR9803968A publication Critical patent/BR9803968A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"BIFENILSULFONILCIANAMIDAS, PROCESSO PARA SUA PREPARAçãO E SEU USO COMO MEDICAMENTO"<D>. Os compostos da fórmula I nos quais os símbolos apresentam os significados indicados nas reivindicações e que apresentam propriedades antiarrítmicas convenientes. Eles exibem um componente cardioprotetor. Eles podem inibir ou diminuir bastante, de um modo preventivo, os procesos patofisiológicos na formação de danos induzidos isquemicamente, particularmente na eliciação de arritmias cardíacas induzidas isquemicamente. Além do mais, eles apresentam uma ação inibitória forte na proliferação de células.
BR9803968-7A 1997-09-22 1998-09-21 Bifenilsulfonilcianamidas, processo para sua preparação e seu uso como medicamento. BR9803968A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19741635A DE19741635A1 (de) 1997-09-22 1997-09-22 Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament

Publications (1)

Publication Number Publication Date
BR9803968A true BR9803968A (pt) 2000-05-02

Family

ID=7843124

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9803968-7A BR9803968A (pt) 1997-09-22 1998-09-21 Bifenilsulfonilcianamidas, processo para sua preparação e seu uso como medicamento.

Country Status (19)

Country Link
US (1) US5968978A (pt)
EP (1) EP0903339B1 (pt)
JP (1) JP4272278B2 (pt)
KR (1) KR19990029983A (pt)
CN (2) CN1212255A (pt)
AR (1) AR015170A1 (pt)
AT (1) ATE210638T1 (pt)
AU (1) AU755553B2 (pt)
BR (1) BR9803968A (pt)
CA (1) CA2247749A1 (pt)
CZ (1) CZ300698A3 (pt)
DE (2) DE19741635A1 (pt)
DK (1) DK0903339T3 (pt)
ES (1) ES2169467T3 (pt)
HK (1) HK1040980A1 (pt)
HU (1) HUP9802132A3 (pt)
PL (1) PL328762A1 (pt)
PT (1) PT903339E (pt)
TR (1) TR199801871A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19737224A1 (de) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen
DE19804251A1 (de) 1998-02-04 1999-08-05 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
BR9908474A (pt) * 1998-03-04 2000-12-05 Takeda Chemical Industries Ltd Preparação de liberação prolongada, processo para a produção de uma preparação de liberação prolongada, e, composição farmacêutica
DE19820064A1 (de) * 1998-05-06 1999-11-11 Hoechst Marion Roussel De Gmbh Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
HUP0103000A3 (en) * 1998-07-20 2002-08-28 Smithkline Beecham Corp Bioenhanced formulations comprising eprosartan in oral solid dosage form and process for their preparation
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US20070160645A1 (en) * 2001-10-25 2007-07-12 Jakob Vinten-Johansen PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs
DE60229416D1 (de) 2001-10-25 2008-11-27 Univ Emory Katheter für modifizierte Perfusion
DE10206354A1 (de) * 2002-02-14 2003-08-28 Aventis Pharma Gmbh Verwendung von Inhibitoren des Natrium-abhängigen Chlorid-Bicarbonat-Austauschers zur Behandlung von thrombotischen und inflammatorischer Erkrankungen
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
US20060099230A1 (en) * 2004-11-10 2006-05-11 Chin-Chih Chiang Novel formulations of eprosartan with enhanced bioavailability
JP2008525468A (ja) * 2004-12-22 2008-07-17 エモリー・ユニバーシティ ポストコンディショニング臓器保護作用を増強する治療補助薬
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography
US7541492B2 (en) * 2005-10-26 2009-06-02 Toyota Jidosha Kabushiki Kaisha Perfluoroalkanesulfonamide compounds
RU2014109079A (ru) 2011-08-12 2015-09-20 Бёрингер Ингельхайм Ветмедика Гмбх Фармацевтическая композиция с маскированным вкусом
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
CN113527152B (zh) * 2021-08-09 2023-07-28 西北农林科技大学 一种联苯磺酰胺类化合物及其防治农作物害虫的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2533127A1 (de) * 1975-07-24 1977-02-10 Bayer Ag Polytriazine und ein verfahren zu deren herstellung
DE2533126A1 (de) * 1975-07-24 1977-02-10 Bayer Ag Polytriazine und ein verfahren zu deren herstellung
CA2062558A1 (en) * 1991-03-08 1992-09-09 Prasun K. Chakravarty Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
EP0503838A3 (en) * 1991-03-08 1992-10-07 Merck & Co. Inc. Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
EP0586513A1 (en) * 1991-05-10 1994-03-16 Merck & Co. Inc. Acidic aralkyl triazole derivatives active as angiotensin ii antagonists
EP0855392A3 (de) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
HUP9802132A2 (hu) 2000-02-28
CN1326928A (zh) 2001-12-19
EP0903339A2 (de) 1999-03-24
PL328762A1 (en) 1999-03-29
AU755553B2 (en) 2002-12-12
CN1212255A (zh) 1999-03-31
EP0903339A3 (de) 1999-03-31
HUP9802132A3 (en) 2000-04-28
AR015170A1 (es) 2001-04-18
EP0903339B1 (de) 2001-12-12
CA2247749A1 (en) 1999-03-22
ES2169467T3 (es) 2002-07-01
KR19990029983A (ko) 1999-04-26
ATE210638T1 (de) 2001-12-15
AU8610898A (en) 1999-04-01
DE19741635A1 (de) 1999-03-25
JP4272278B2 (ja) 2009-06-03
TR199801871A3 (tr) 1999-04-21
HU9802132D0 (en) 1998-11-30
CZ300698A3 (cs) 1999-04-14
TR199801871A2 (xx) 1999-04-21
HK1040980A1 (zh) 2002-06-28
PT903339E (pt) 2002-06-28
DE59802412D1 (de) 2002-01-24
US5968978A (en) 1999-10-19
JPH11189581A (ja) 1999-07-13
DK0903339T3 (da) 2002-04-08

Similar Documents

Publication Publication Date Title
BR9803968A (pt) Bifenilsulfonilcianamidas, processo para sua preparação e seu uso como medicamento.
BR0014465A (pt) 1,1&#39;-bifenil-2-carbonamidas 2&#39;-substituìdas, processos para a sua preparação,seu emprego como medicamento bem como os preparados farmacêuticos contendo as mesmas
BR9800436A (pt) &#34;heterociclos com cinco membros tendo substituição bifenilsulfonila, processos preparação dos mesmos, uso dos mesmos como medicamento ou diagnóstico e medicamento contendo os mesmos&#34;.
MALMFORS et al. Direct studies on the disappearance of the transmitter and changes in the uptake‐storage mechanisms of degenerating adrenergic nerves
BR0207502A (pt) Compostos, enanciÈmeros, composição farmacêutica, uso de compostos, e, processo para a fabricação de compostos
BR0014804A (pt) Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto
DE60210752D1 (de) Pharmazeutische zusammensetzung enthaltend proteoglykan und ihre verwendung zur behandlung von entzündlichen erkrankungen
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
BR9915940A (pt) Métodos e composições para restaurar a estabilidade conformacional de uma proteìna da famìlia p53
BR0112841A (pt) Sistemas de revestimento de camadas múltiplas de uma camada de base semelhante a gel, de camada espessa, e uma camada de cobertura de laca de poliuretano, produção e uso dos mesmos
BR9814672A (pt) Preparação farmacêutica sob a forma de comprimidos de esferóides e processo de fabricação da mesma
BR9910898A (pt) Indolinonas sibstituìdas, preparação e utilização das mesmas como composições farmacêuticas
KR950031059A (ko) 골다공증 치료용 약제학적 조성물
DK485787D0 (da) Plantebeskyttelsesmiddel paa basis af suspoemulsioner indeholdende vandige og organske faser
BR0007589A (pt) Inibidores da proliferação de células
BR9810177A (pt) Composto, formulação farmacêutica, uso de um composto, e, processos para tratamento de uma condição onde a inibição da trombina é requerida e para a preparação de compostos
BR9913705A (pt) Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin
BR9908427A (pt) Composições farmacêuticas e uso das mesmas
BR0016678A (pt) Composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto
BR0206791A (pt) Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto
BR0312702A (pt) Derivados de 3-guanidinocarbonil-1-heteroaril-pirrol, processo de preparação e intermediários desse processo, seu uso como medicamentos e composições farmacêuticas compreendendo os mesmos
BR0009838A (pt) Dissulfetos cìclicos de pirrolidincarbonilamino
BR9912241A (pt) Derivados de imidazol com substituição bifenilsulfonila, processos para a sua preparação, seu emprego como medicamento ou diagnóstico
AR008761A1 (es) Benzoil-guanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento, asi como medicamento que las contiene
BR9800989A (pt) Benzoilguanidinas orto-substituìdas, processo para a sua preparação, seu uso como um medicamento ou diagnostico, e medicamento compreendendo as mesmas.

Legal Events

Date Code Title Description
TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1861 DE 05/09/2006.